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Nerve Growth Factor (NGF), the prototype of the neurotrophin family, is essential for
maintenance and growth of different neuronal populations. The X-ray crystal structure of
NGF has been known since the early ’90s and shows a β-sandwich fold with extensive
loops that are involved in the interaction with its binding partners. Understanding the
dynamical properties of these loops is thus important for molecular recognition. We
present here a combined solution NMR/molecular dynamics study which addresses the
question of whether and how much the long loops of NGF are flexible and describes
the N-terminal intrinsic conformational tendency of the unbound NGF molecule. NMR
titration experiments allowed identification of a previously undetected epitope of the
anti-NGF antagonist antibody αD11 which will be of crucial importance for future drug
lead discovery. The present study thus recapitulates all the available structural information
and unveils the conformational versatility of the relatively rigid NGF loops upon functional
ligand binding.
Keywords: antibody recognition, NGF, neurodegeneration, neurotrophins, NMR, structure
INTRODUCTION
Nerve Growth Factor (NGF), the prototype of the neurotrophin family, is essential for maintenance
and growth of different neuronal populations in the nervous systems (Levi-Montalcini, 1987).
Alterations in its homeostatic regulation are involved in severe pathologies (Tiveron et al., 2013;
Mysona et al., 2015). NGF is translated as a precursor, proNGF, with distinct biological functions
(Hempstead, 2014). An early event in NGF signal transduction is the interaction with p75NTR
and/or TrkA receptors (Lewin and Carter, 2014). Because of its role in the pathway of pain
(Capsoni, 2014; Kelleher et al., 2017), there is a substantial interest in developing NGF mimetics
endowed with antagonistic properties. However, this strongly relies on a detailed knowledge of its
structure and of the interactions with its receptors.
The X-ray crystal structures of NGF have been known since the early 90s (McDonald et al., 1991;
Holland et al., 1994). NGF is an obligate non-covalent head-to-head homodimer with three loops (I,
II, and V) at one end of the molecule, whereas the opposite end contains a loop structure (III) and
Paoletti et al. The Dynamic Properties of Nerve Growth Factor
the conserved cystine-knot arrangement of the three intra-
chain disulphide bonds. A distinctive feature of NGF are its
long unstructured loops (I, II, III, and V), important for its
interactions with the binding partners.
Also available are the structures of NGF bound to its receptors
(Wiesmann et al., 1999; He and Garcia, 2004; Wehrman et al.,
2007; Feng et al., 2010), neutralizing antibodies (Covaceuszach
et al., 2008; La Porte et al., 2014), and small ligands, such as
lysophospholipids (Tong et al., 2012; Sun and Jiang, 2015) and
DNA-aptamers (Jarvis et al., 2015). These studies have led to an
emerging picture of the binding determinants on NGF to its key
receptors.
Despite the wealth of structural information obtained from
the extensive crystallographic investigations, some significant
questions have remained elusive: (i) is the NGF N-terminus
unstructured in the absence of ligands or does it already have
some intrinsic conformational tendency? (ii) how flexible/rigid
are the loops and how their dynamics may reflect on the overall
structural plasticity of mature NGF? (iii) how much do the loops
contribute to antibody recognition?
Structural information is thus extremely important, in view
of structure-based design of effective non-peptidic antagonists
of NGF activity on TrkA receptor. Accumulating evidence
shows that the NGF N-terminus plays a role in a number
of processes. An N-terminal truncated form of NGF has a
significant drop in affinity for TrkA and in the ability of eliciting
TrkA phosphorylation (Kahle et al., 1992; Hughes et al., 2001)
which could not be ascribed to differences in folding or stability
(Woo et al., 1995). In one of the two crystal structures of NGF
purified from mouse salivary glands (mNGF), the N-terminus is
absent (Holland et al., 1994) whereas in the other neither N- nor
C- termini were defined (McDonald et al., 1991). The N-terminus
in recombinant human NGF (hNGF) or mouse proNGF in
complex with p75NTR are not defined (He and Garcia, 2004; Feng
et al., 2010). Only in the hNGF/TrkA complex (Wiesmann et al.,
1999; Wehrman et al., 2007) and in one of the two protomers
of a complex with a DNA aptamer (Jarvis et al., 2015), is the
N-terminus defined and folded in an α-helix. The generally
accepted view is thus that the N-terminus is disordered in the
NGF unbound state (Settanni et al., 2003; Berrera et al., 2006).
Similar conclusions have been recently reached as result of CD
and NMR solution studies and molecular dynamics simulations
on two linear hNGF N-terminus peptides (Stanzione et al., 2010;
Travaglia et al., 2015).
It is difficult to infer from the X-ray data whether the
variations reflect authentic flexibility or rather a structural
plasticity. The two terms are similar but not equivalent: In the
context of a protein, we would consider plasticity the capacity
of a region to change the conformation permanently under, for
instance, an interaction; flexibility is the property of a region (e.g.,
a loop) not to have a fixed conformation. In other words, one is a
static concept, the second dynamic. The difference is particularly
important for the design of antibodies directed against specific
regions of NGF. Among the existing anti-NGF antibodies,
the well-characterized therapeutic MAb αD11 (Cattaneo et al.,
1988; Covaceuszach et al., 2012) is particularly interesting as a
structural probe, because it recognizes preferentially the mature
form of NGF vs. proNGF (Paoletti et al., 2009). This property
has been used to study the mechanistic consequences of inducing
experimentally an imbalance in NGF/proNGF (Capsoni and
Cattaneo, 2006; Capsoni et al., 2011). TheMAb αD11 epitope has
been characterized by ELISA, and the structure of the complex of
rat αD11FAb and hNGF was obtained by in silico computational
docking and validated by SAXS experiments (Covaceuszach et al.,
2008).
We present here a study in solution which addresses the
open questions. Using a combination of nuclear magnetic
resonance (NMR) and molecular dynamics (MD), we describe
the N-terminal intrinsic conformational preferences of unbound
NGF in solution. We also show that in the absence of partners
the NGF N-terminus has a strong tendency to fold into a helix,
challenging the current view that this region is unstructured. Our
study also sets a definitive word on the structural plasticity of
NGF loops II and V and provides a structural explanation for
the large differential affinity of the αD11 anti-NGF therapeutic
antibody for NGF vs. proNGF. We demonstrate by solution
NMR epitope mapping with the MAb αD11 the presence of
a previously undetected epitope. The present study thus fills a
gap in our structural understanding of NGF inter- and intra-
molecular interactions and provides a strong basis for the design
of more selective NGF antagonists.
RESULTS
Solution NMR Structure of Mouse NGF
Assigning the NMR spectrum to the specific protons of a protein
is the prerequisite to map interactions and any conformational
change. At 30◦C, the 2D 1H -15NHSQC of mNGF is optimal and
reveals a wide dispersion of signals characteristic of proteins with
a predominantly β-sheet content which is consistent with the X-
ray structure. The indole correlations of the three Trp residues
are clearly observable in the distinctive and typically isolated
region of the spectrum around 10.5 ppm (1H) and 135 ppm
(15N). All Gln and Asn side chains are detected. We achieved
virtually full assignment of the spectrum. Conversion of the
NOE information into a structural model was not trivial because
the potential symmetry (two-fold) of the homodimer makes it
hard to distinguish between intra- and inter-molecular NOEs.
The problem, which has been debated for years (Saudek et al.,
1991; Nilges and O’Donoghue, 1998), was circumvented thanks
to the software support of ARIA (Rieping et al., 2007) which
allows discrimination of intra- from inter-molecular NOEs and
careful iterative analysis of the violations (Table 1). The process
led eventually to a well-converged ensemble (Figure 1A) with a
root mean square deviation (r.m.s.d.) of 1.3 Å from the structure
with the lowest global energy as calculated on 236 residues
(Figure 1B). It closely resembles the available X-ray structures,
especially in the Cys-knot, while exhibiting larger variability in
the loop regions (Figure 1C). The r.m.s.d. values between the
structure with the lowest global energy and the crystal structures
of unbound mNGF (PDB ID 1BTG, protomers B,C) or NGF
bound to lipids (PDB ID 4EAX or 4XPJ) for the backbone
atoms of the core residues (15–22, 51–58, 78–89, 100–111) which
exclude the loops are 2.32, 2.14, and 2.12 Å respectively. The
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TABLE 1 | NMR refinement statistics of NGF.
COMPLETENESS OF RESONANCE ASSIGNMENTS
Backbone (%) 97.3
Side Chains (%) 72.9
NMR DISTANCE AND DIHEDRAL RESTRAINTS
Distance restraints
Total NOEs (used during calculations—per protomer) 2327
Unambiguous 2315
Ambiguous 12
Merged 4331
Intra-residuea 1346
Inter-residuea 969
Sequential (|i–j| = 1) 421
Non-sequential (|i–j| > 1) 548
Hydrogen bonds (per protomer) 46
No. of Noe restraints per residue 19.9
Total dihedral angle restraintsb (per protomer)
Phi angles 55
Psi angles 56
Inter-protomer restraints (per protomer) 33
STRUCTURE STATISTICS
Violations
Distance constraints (>0.3 Å) 5
Deviations from idealized geometry (over 60 structures)
Bond lengths (Å) 0.0035 ± 0.00009
Bond Angles (◦) 0.47 ± 0.016
Improper Angles (◦) 1.46 ± 0.13
Ensemble RMSD (over 60 structures in the refinement
process)
All residues
Backbone (N,CA,C,O) (Å) 2.58 ± 1.18
Heavy atoms (Å) 2.89 ± 1.11
Ordered residuesc
Backbone (N,CA,C,O) (Å) 1.44 ± 0.64
Heavy atoms (Å) 1.77 ± 0.57
aStatistics among unambiguous restraints.
bTALOS-derived dihedral restraints.
cOrdered residues (for A and B protomers): 5–6, 14, 17–24, 27–38, 41–43, 47–48, 53–58,
63, 67, 70–71, 75–82, 84–92, 97–112, 114.
structure in solution allows us to address a number of crucial
aspects as detailed in the following sections.
The Structure of the NGF N-Terminus
From our data, we can obtain direct information on the structure
of the N-terminus (residues S1-M9) from the NOE patterns.
In solution, the N-terminus, whose resonances can be observed
distinctly, does not adopt a regular secondary structure. However,
a number of medium-range NOEs were observed between the
backbone and side-chains of these residues, suggesting the
existence of a short nascent helical turn (residues 6–10). The
average Oi...NHi+3 and Oi...NHi+4 distances between residues
S2-G10 were measured for the 20 lowest global energy models to
check the presence of distances compatible with hydrogen bonds.
Overall, the V6-G10 segment has a clear propensity to form a
short helix, the Oi...NHi+3 and Oi...NHi+4 distances being within
FIGURE 1 | Solution structure of recombinant mNGF. (A) Overlay of the
20 lowest global energy models after ARIA refinement in water. Inset:
Subgroup of 11 structures with a nascent helical structure of the N-terminus.
(B) Cartoon model of the lowest global energy model for mNGF with the
position of the loops indicated. The accepted nomenclature for neurotrophins
was used (McDonald et al., 1991). (C) Structural alignment of the X-ray crystal
structures of mNGF. They are color coded in green (1BTG, protomers B,C),
gray (4EAX, protomers A,B), red (4XPJ).
2.6 and 6.1 Å over the whole bundle. In almost 50% of the 20
lowest global energy models, the V6-G10 segment adopts either
a 310 helix or a α-helix conformation (Figure 1A, inset). These
distances are within 2.1 and 6.2 Å in the lower global energy
model exhibiting a helical conformation. These results provide
a clear answer to whether and how much the N-terminus is
folded and clarify its tendency to fold into a helical conformation.
The secondary chemical shifts, that is the difference between the
observed values and the random coil values for the same amino
acid, confirm a helical tendency of this region (data not shown).
The NGF Loops Are in a Slow
Conformational Exchange
While assigning the NGF spectrum which was troublesome due
to significant overlap, it became clear that some interesting
dynamical processes were going on. At 30◦C the vast majority
of the peaks have homogeneous intensity but a limited set of
resonances of weaker intensity are observed (Figure 2A). After
virtually full spectral assignment, these weaker resonances were
found to be duplicate assignments for a small set of specific
resonances which cluster around loops I and II and on the
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stem region (region IV-loop V) that points toward loop II
(residues 39–47) (Figures 2B,C). Notably, W99, present in this
region, shows doubling of the indole proton. Loop II, the
region where most of the resonance splitting is observed, is also
involved in small ligand binding (PDB ID 4EAX and 4XPJ).
Peak doubling was furthermore observed for the side chains
of a few residues in the 13C HCCH-TOCSY and 13C NOESY-
HSQC spectra (data not shown). To test for the presence of
conformational exchange, 15N HSQC spectra were recorded
at 10◦C intervals between 10◦C and 40◦C (Figure 2A). At
10◦C, the peak intensity is highly heterogeneous with only ca.
30% of the number expected for a homodimer of 118 amino
acids. By progressively increasing the temperature to 40◦C, all
the expected signals return, with the vast majority showing
homogeneous intensity. However, a subset of secondary species
of lower intensity remained observable. The overall quality of
the spectrum is consistent with that expected for a homodimer
of 26 kDa, with a line width indicative of the molecular size
of the system. For a homodimeric protein, resonance doubling
can be explained in at least two possible ways. It could indicate
an intrinsic local asymmetry of the homodimer over the NMR
timescale. This possibility can, however, be ruled out since
the most affected region around loop II is not engaged in
the homodimer interface. Alternatively, it could arise from the
presence of multiple conformational species in equilibrium on
the slow-exchange timescale. This second possibility seems more
likely given the dramatic change in the number and in the relative
peak intensities observed in the 15N HSQC as a function of
temperature.
The data thus suggest that the NGF loops adopt different
conformations in the slow exchange regime in the NMR
timeframe.
Dynamical Features of the NGF loops
We measured the T1, T2 and heteronuclear NOE (hetNOE)
parameters to obtain information on the dynamics in solution.
The experimental correlation time (TC) is 14.8 ns which is
consistent with the expected molecular weight of the dimer.
The T1, T2, and NOE values correlate well with the secondary
structure (Figure 3A) and highlight the more rigid β-sheet
regions. The loops, especially II and V, and the C-terminus are
relatively more flexible showing hetNOE values lower than the
average (0.7). However, overall, the hetNOE profile is relatively
flat with some minor exceptions which could well be explained
by residue overlap.
Intrigued by these results, we ran a molecular dynamics
simulation of mNGF (200 ns) to further explore the tendency
of the N-terminus to adopt a helical conformation and the
conformational space of the loop regions. The ensemble of
structures sampled in the MD trajectory is variable, but in line
with the NMR analysis (Figure 3B). Not having imposed any
symmetry constraints we see of course a different behavior in
FIGURE 2 | NGF is in a conformational exchange regime. (A) Effect of a temperature scan from 10 to 30◦C on the 15N HSQC spectra of NGF. (B) Close-up of
one of the regions of the 2D 1H-15N-HSQC at 30◦C showing the presence of double species. In blue the main species, in red the secondary ones. (C) Mapping on
NGF structure (blue) of the residues showing a double species in the spectra (red). The residues where peak splitting was observed were: V36-I44, A89-T91, W99
(amidic indole only).
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FIGURE 3 | The dynamics of NGF in solution. (A) 15N—NMR relaxation studies. Plots of the T1/T2 and 15N-1H NOE of mNGF at 600 MHz and 30◦C. The
secondary structure is shown above. (B) R.m.s.d. fluctuations along the 200 ns MD simulation of NGF vs. residue position for the two protomers (blue—protomer x;
red—protomer y). (C) Evolution of the distances (Å), along the 200 ns MD simulation, between atoms engaged in the hydrogen bonds that stabilize the helical
structure of the N-terminus of mNGF (gray—protomer x; black—protomer y). (D) Percentage of time, along the 200 ns MD simulation, that each residue spent in a
helical conformation along the trajectory.
the two protomers. Over the simulation time scale, all residues
in the tract His4-Phe7 spend a significant percentage of time in
a 310 or α-helix conformation at least in one of the protomers
(Figure 3C). Residues H4-G10, in both protomers, unwind and
fold during the simulation but are able to form transient
hydrogen bonds mostly between the carbonyl oxygen of H4
and the amide hydrogen of F7 and the carbonyl oxygen of P5
and the amide hydrogen of H8. The carbonyl oxygen of V6
is also engaged only in one protomer in hydrogen bonds with
the amide hydrogen of either M9 or G10 residues. The main-
chain–side-chain interactions between residues H4/F7, V6/M9,
and F7/G10 are overall more preserved than the side-chain–
side-chain interactions between residues P5/H8 and V6/M9 as
well as the interaction between the residues V6/G10. The MD
results are in line with the observed NOE contacts supporting
that in at least one of the protomers (Table S1), a short
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segment within the central region of the mNGF N-terminus
adopts a α-helix (15%) or a 310-helix (35%) conformation for
a small but significant fraction of time (Figure 3D). According
to these conclusions, a previous MD study on an isolated
linear peptide spanning the N-terminal sequence (Stanzione
et al., 2010) has shown that most of the adopted conformations
do not present a regular secondary structure but a helical
structure can form for a limited fraction of conformers in the
ensemble.
We can thus conclude that the NGF N-terminus comprises a
nascent helix which can be further stabilized upon binding with
its partners.
Analysis of the Loop Motions
The Cα r.m.s.d. along the MD trajectory shows that, besides the
N- and C-termini, the regions encompassing loops II and V are
comparably more flexible and exhibit large-scale conformational
flexibility (Figure 3B). The loop variations are however relatively
small as compared to the flexibility of the N- and C-termini.
This indicates that the loops are plastic but not flexible in
agreement with the differences observed in these regions in the
crystallographic structures of apo mNGF (PDB ID 1BET, 1BTG)
and in complex with lysophosphatidylserine (PDB ID 4EAX)
and lysophosphatidylinositol (PDB ID 4XPJ). This information
is of crucial importance for the development of small organic
compounds (Brahimi et al., 2014) and peptidomimetics based
on the combination of different NGF loop fragments (Colangelo
et al., 2008). We thus analyzed the relative intra- and inter-
protomer distances between loops I, II, III, andV (Figure S1). The
shortest and the longest inter-protomer Cα distances between
the Asn46 of Loop II are 11 Å (apo form PDB ID 1BTG,
protomers B,C) and 30 Å respectively (holo forms PDB ID 4XPJ,
protomers A,B and PDB ID 4EAX, protomers A,B and C,D)
indicating large scale motions. The corresponding distances,
in the most representative MD structure (the most populated
cluster center) and in the lowest global energy NMR structure
are 13 and 16 Å respectively. The longest and shortest inter-
protomers distances between Lys95 of Loop V are 42 Å (apo form
PDB ID 1BTG, protomers B,C) and 40 Å (holo form PDB ID
4XPJ). The corresponding distances in the most representative
MD structure (the most populated cluster center) and in the
lowest global energy NMR structure are 34 and 37 Å respectively
(Figure S1).
For comparison, in the crystal structures of free and bound
NGF, the conformation of loop II has high plasticity with an
overall opening of the structure upon the accommodation of
the small ligands (Figure 1C). It is tempting to speculate that
the conformational equilibrium experienced by loop II and V,
supported also by resonance doubling, is functionally relevant
for the biological activity of the molecule, including interactions
with the binding partners, i.e. the receptors TrkA and p75NTR.
These features highlight the differences between NGF and other
homodimeric β-sandwich structures.
We can thus conclude that NGF has long plastic but relatively
rigid loops. This information is of crucial importance for drug
design (Bannwarth and Kostine, 2014).
Using the Spectral Assignment for
Antibody Recognition Studies
Finally, we used the information gained in solution to study the
interaction of NGF with αD11, one of the well-characterized
antibodies. We titrated 15N-labeled NGF with αD11 using the
MAb protein. We used sub-stoichiometric amounts of αD11
to allow the observation of shift changes, given that the high
affinity expected and the large molecular weight of the complex
could prevent observation of the signals at stoichiometric
concentrations (Figure 4A). The most appreciable perturbations
in the NGF spectrum occur in three distinct sets of resonances
which disappear (V14, G23, F101, C110, V111), decrease in
intensity (T26, L39, N45, N46, Y52, E65, D93, W99, R100,
K115) or shift significantly (G10, S13, V18, A40, F49, T56, Y79,
T81, T92, E94, K95, Q96, I102, V109) indicating slow, slow-
intermediate and fast-exchange regimes, respectively. When
mapping these regions onto the NGF structure, a set of the
affected residues (V18, G23, T26, L39, A40, F49, Y52, D93, Q96,
W99, R100, F101) overlap with those previously identified in
the SAXS hNGF-αD11 FAb complex model (Covaceuszach et al.,
2008). Additionally, residues G10-V14, V64-I71, T81, and V109-
V111, which cluster close together in space, suggest a previously
unidentified epitope (Figure 4B). Interestingly, this region is not
included in the FAb-NGF contacts in the crystal structures of the
complexes of hNGF with the anti-NGF antibodies Tanezumab
(PDB ID 4EDW) and its murine precursor MAb 911 (PDB ID
4EDX), whose epitopes are otherwise comparable to those of
αD11 FAb. Thus, the solution NMR epitope mapping of the
MAb αD11 unveiled a previously undetected epitope, further
supporting why αD11 antibody binding differs significantly
between mature NGF and proNGF: in the latter the pro-
peptide could hinder the accessibility of the NGF surface to the
antibody.
DISCUSSION
NGF is an important molecule involved in the maintenance
of numerous neuronal populations, and its alterations in
metabolism are crucial for different neurological disorders. The
crystal structures of mNGF have been known for 25 years
(McDonald et al., 1991; Holland et al., 1994), but no solution
structure has so far been available which could facilitate drug
design and small molecule screening in solution. The present
study fills this gap, by reporting the mNGF structure in solution
and sheds light on local conformational and dynamical features
supported by MD simulations.
For the first time we have experimentally characterized the
N-terminus of the protein, a dynamic and elusive segment
of NGF which was previously only observed in the structure
of recombinant hNGF in complex with TrkA receptor while
it is cleaved or unobservable in other structures. This region
is considered a structural determinant in NGF molecular
recognition and selective binding of the TrkA rather than p75NTR
receptor (Wiesmann et al., 1999; He and Garcia, 2004; Wehrman
et al., 2007). Our data indicate that, in the context of the full
length mNGF, a helical conformation is readily sampled in
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FIGURE 4 | Anti-NGF Antibody-antigen interaction. (A) Superimposition
of the 15N-HSQC recorded at the different points of the titration of mNGF with
the MAb αD11. The spectra were recorded at 30◦C. Red: 0 antibody
equivalents; Green: 0.15 antibody equivalents; Purple: 0.45 antibody
equivalents. (B) Structure of mNGF (PDB ID 1BET) with the residues of the
αD11 epitope highlighted in green. Residues found to be affected in the
present titration but not previously known to participate to the epitope are
highlighted in red. Insets: Close-ups of the residues most affected by
broadening or chemical shift perturbation. Their positions on the structure is
indicated by arrows.
solution among the energetically favored states of this region as
in a classical nascent helix. This result challenges the current view
that the NGF N-terminus is unstructured and adopts a helical
structure only upon binding to its partner TrkA (Wehrman et al.,
2007). Our findings open up new strategies for the development
of effective NGF N-terminal based bioactive peptide-based
compounds as antagonists with high-affinity toward the TrkA
receptor.
From a careful analysis of the resonances in the 15N- and
13C-HSQC and the corresponding NOESY-HSQCs, it was also
possible to identify the splitting of several resonances. The
residues involved are all concentrated in the region of the
molecule encompassing loops I and II and the facing region
IV/loop V. The occurrence of these extra resonances likely
results from a slow exchange between conformational species,
thus pointing to an increased mobility of the loops II and V
within the frame of an otherwise rigid molecule. Accordingly,
these regions have relatively lower values of hetNOEs and a
higher r.m.s.d. in ourMD trajectory although overall the motions
look only local. These observations agree with the structural
information available for other members of the neurotrophin
family (Butte et al., 1998; Robinson et al., 1999; Banfield et al.,
2001; Gong et al., 2008) and with the observation that the
region encompassing loops II and V is the one in which a
conformational rearrangement/breathing is triggered by binding
of lysophospholipids (Tong et al., 2012; Sun and Jiang, 2015).
We can rationalize these results considering that loops II and
V can be considered like forceps that open/close and are in a
cross-talk to adapt and sequester the ligand. Loops I are spatially
close to loops V but do not move. They could thus be considered
like a “guard rail” preventing excessive motions of loops V and
consequent disruption of the binding site formed by loops II
and V. Loop III protects the cystine-knot. It is spatially far
from loops I, II and V, but in proximity of the N- and C-
termini. It is not flexible in agreement with its likely role of
protection even though it is peculiar that this loop has partially
defined electronic density in the crystallographic structures of
human NGF in complex with the TrkA and p75NTR receptors,
as well as in complex with the DNA-aptamer and with antibodies
and it is among the least conserved in length and composition
within the neurotrophin family members (NGF, BDNF, NT-3,
NT-4).
Finally, the present NMR study exploits the interaction
between NGF and the MAb αD11 antibody allowing a fine
mapping of the epitope: We observed a patch encompassing
residues G10-V14, V64-I71, T81, and V109-V111, as being
involved in addition to loop I and II which had already
been identified (Covaceuszach et al., 2008). These regions face
each other in the structure. The observation is important
for the interpretation of the binding properties of αD11
which recognizes both mature and proNGF albeit with
very different affinities (pM vs. nM). Since αD11 is an
NGF neutralizing antagonistic antibody (Covaceuszach et al.,
2008), knowledge of the exact epitopes is of interest for
interpreting mouse models and for the design of more effective
antibodies.
In conclusion, our study reports the first NMR study of mNGF
in solution, and, more generally, of a neurotrophin and provides
new insights into the dynamical features of NGF N-terminus
and loops, opening the way to further studies aimed at a deeper
understanding of NGF binding to its partners. It also paves the
way to the determination of the high resolution structure of the
mNGF precursor, mproNGF, whose only available 3D structural
information is limited to low resolution SAXS studies (Paoletti
et al., 2009) and preliminary solution NMR studies (Paoletti et al.,
2011).
Experimental Procedures
Expression, Refolding, and Purification of mNGF
Recombinant mNGF was expressed in minimal medium, both as
15N and a 15N-13C labeled proteins, and purified as previously
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described (Paoletti et al., 2011). See Supplementary Information
for details.
NMR Spectroscopy Experiments
NMR experiments and structure calculations were carried
out using standard protocols (details in Supplementary
Information). Briefly, HNCA, HNCO, HNCACB were used for
backbone assignments. 15N NOESY-HSQC, 13C NOESY-HSQC,
CBCACONH, and HCCH-TOCSY were used for side chain
aliphatic assignments. (Hβ)Cβ(CγCδ)Hδ and (Hβ)Cβ(CγCδ)Hε
were used in combination with 13C-HSQC, 13C- NOESY-HSQC,
and HCCH-TOCSY tuned for the aromatic resonances for
the assignment of the aromatic side chains. All spectra were
processed using NMRPipe/NMR-Draw (Delaglio et al., 1995) and
analyzed using CARA (Keller, 2004). Backbone and side chain
assignment was deposited in the BMRB database (accession code
34037).
Relaxation parameters were obtained by spectra recorded at
600 MHz and 30◦C and extracted using peak picking, lineshape
fitting, and exponential modeling as implemented in NMRPipe
(Delaglio et al., 1995).
Structure Determination
Automated NOESY cross-peak assignments and structure
determination were performed using the ARIA 2.3 software
(Rieping et al., 2007). The input used to generate the final
structures consisted of NGF intra-molecular NOE cross peaks
from 15N- and 13C-NOESY-HSQC spectra (at 30 and 35◦C),
along with a set of ϕ and ψ backbone dihedral restraints derived
by TALOS+ (Shen et al., 2009) and a set of manually assigned
unambiguous inter-protomer restraints. After refinement of
the 60 lowest global energy structures by molecular dynamics
simulation with explicit water, 20 structures ranked on global
energy were selected as representative of the structure and
used for statistical analysis. Structure quality was evaluated with
PROCHECK-NMR (Laskowski et al., 1996). The details are
reported in the Supplementary Information.
The coordinates of the NGF structure are deposited in the
PDB under the code 5LSD.
Molecular Dynamics Simulations and Analysis
A molecular model of the full length mNGF encompassing
residues (2–118) was built (Covaceuszach et al., 2015) from
the crystal structures of mouse bis-des-octa β-NGF (PDB
ID 1BTG, protomers B,C). Molecular dynamics simulation
(MD) was performed using the GROMACS software
package (version 5.1.2) (Hess et al., 2008) conjugated with
the Amber99SB force field. Details are reported in the
Supplementary Experimental procedures. The utilities gmx
distance and gmx cluster, provided in the GROMACS package,
were used: (i) to calculate the distances between pairs of
positions as a function of time; (ii) to cluster, in the post
processing phase, the resulting trajectories with a cutoff of
0.15 nm, calculated on the backbone atoms (Daura et al.,
1999).
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